Medtechweek

The second European Medtech Week from 13-17 June was a platform actively leveraged by all stakeholders to discuss the potential of MedTech. Over 100 events took place in 18 European countries as part of MedTech Week, with the medtech industry and our various partners discussing topics that were high on their national agendas. National medtech associations and individual companies demonstrated how medical technologies save and transform peoples’ lives. It was great to see healthcare professionals and patients from very different backgrounds and regions across Europe sharing their first-hand, insightful experiences, as well as their views on what needs to change in order to improve their daily lives. One of the topics that was discussed in a number of countries was the role and potential of eHealth. This is a subject very close to my heart because I believe it will be a key enabler for moving healthcare in the right direction. Based on the feedback from a range of events across Europe, we can see there seems to be strong agreement amongst all stakeholders that three important issues need to be addressed in order to use the full potential of eHealth: - We need a safe regulatory environment for e-products and services - We need to adapt funding schemes appropriately to allow access to e-products and e-services - We must move forward in terms of interoperability of products, services and systems Clear and timely action on these areas would allow eHealth to facilitate solutions to a range of healthcare challenges: using big data, embracing health apps, and deploying remote solutions in the most efficient way for the benefit of patients and doctors. I believe this year’s European Medtech Week showed that our industry has grown up and is now a reliable and relevant partner seeking to be a responsible participant...
Question: As an active leader in the heart failure conversation and the instigator of the Heart Failure Aware campaign, could you tell us more on what it’s trying to achieve, target, why is it important, and how you could see it rolled out across Europe? Currently we are facing a number of large unmet challenges in heart failure across Europe. There is no parity in access to care, variations exist across Europe; I say this because we know what we should be doing, but we’re not doing it. 15 million people in Europe have heart failure; it’s a tsunami that will hit the shores of Europe’s health systems, it’s not on the agenda – politically, economically or even amongst the public. It is a poor relation in comparison to other conditions. One of the challenges we face includes a lack of access to innovation across all therapeutic areas in heart failure. Patients when diagnosed aren't generally aware of the therapy options and pathways. Heart failure patients don't know until they have been managing their condition for a long time, of the treatment options potentially available to them such as cardiac devices. Awareness of medtech products and therapies is very low in the heart failure patient community, and it’s even worse around the innovations. The reason I founded the Pumping Marvellous Foundation was because patients and their families were under-served and were in need of knowledge, information and techniques to manage their heart failure – and an essential element to this is knowing what is available, our patient community call this ‘hope’. We developed a heart failure community platform on Facebook because it was free and social media plays a big part in people's lives. Recent studies have suggested, that our assumptions around older persons use of social media is wrong,...
The medical technology industry creates over half a million different products, from pacemakers and artificial hips to condoms and pregnancy tests. Despite the impact these products have on millions of people of all ages every day, medtech is still a little known and often misunderstood sector. With European MedTech Week now in its second year, we want to change this. From 13-17 June, the MedTech sector is hosting activities across the continent to raise awareness of the industry and the life-changing innovation we invest in and provide. MedTech Week is a chance for the entire healthcare community to discuss the future of Europe’s health and how medical technology can address current challenges and ensure more sustainable pathways of care. There is a lot that we can do. The medtech sector is at the cutting edge of research and development. It employs some of the world’s most skilled doctors, engineers, and scientists. From prevention to diagnosis, treatment and cure medtech innovations are absolutely crucial to public health and patient wellbeing. For my part, I also see MedTech Week as an opportunity to reinforce our industry’s commitment to high ethical standards. Our sector works closely with healthcare professionals to develop new and innovative technologies that drive improvements in patient care. Commitment to a robust Code of Ethical Business Practice safeguards these important relationships. This is why MedTech Europe recently endorsed an updated ‘Code’ which applies both to device and diagnostic companies. The Code provides a clear framework for open and transparent interactions between industry and healthcare professionals, ensuring that patients can continue to benefit from these collaborations. The medtech industry partners with all types of professionals on a daily basis so I am delighted that this year, the dedicated website for European MedTech Week www.medtechweek.eu will feature their perspectives, along with those...
European MedTech Week, 13-17 June 2016 I am excited to see MedTech Week return for the second year. MedTech Week aims to bring people and organisations together to discuss and discover how medtech transforms people’s lives. Last year’s first European MedTech Week was a huge success: 40 events took place across 17 countries with 34 companies engaged. The online activity was particularly outstanding: there were 82,013 social impressions across Twitter, LinkedIn and Facebook. We are hoping for bigger and better this year and hope you will come on board with us in June. This year’s theme, from diagnosis to cure , embraces how medical technology saves lives and improves health across the patient pathway. Moreover, our initiatives on the ground will be multi-regional and multi-faceted. We have a wide range of healthcare discussions planned, from conversations on sustainable systems and procurement in Sweden, to looking at awareness and understanding of medical technologies in Ireland. These conversations, which aim to find answers and explore solutions, reflect today’s healthcare environment. Patients are increasingly moving towards greater self-management and empowerment when it comes to treatment choices and lifestyle changes. Simultaneously, healthcare systems are facing challenges and value-based financing is increasingly a focal point for health ministries. Amidst all of these discussions and challenges, we cannot lose sight of the needs of patients and their families. I believe medical technologies play a crucial role in covering those needs: from devices and tests which support a new life in his or her first minutes, to technologies which enable assisted care in the community for older persons, medtech plays a role throughout people’s lives. Underpinning this is the value of diagnostics which can test and monitor thousands of conditions and infectious diseases, leading to faster and more effective live-saving treatment for millions. But none of this...
Do you remember the last time you have used a medical technology product? I think a lot of people, including myself, will answer that it was quite recent. In fact, medical technology is all around us - diagnosing, monitoring and treating virtually every disease or condition. And in the 2nd edition of the European MedTech Week from 13 to 17 of June 2016, everyone will be able to explore how medical technologies help in saving and transforming our daily lives. What is MedTech Week? European MedTech Week aims to raise awareness and create a conversation about medical technology. Innovative companies, national associations and stakeholders in health, including patients, professionals, and carers, will tell how devices and diagnostic tests are transforming our lives and our health. At the first ever MedTech Week last year, we celebrated the value of medical technology via radio programmes, scientific conferences, press interviews, patient testimonials, and museum donations. You can see a summary of our 2015 activities in the MedTech Week magazine . What will happen during MedTech Week 2016? This year, we’ll build on the last edition’s success and promote the diversity, innovation and creativity of the sector. Together with our members, we are putting in place policy roundtables, visits to manufacturing sites, partnerships with patient groups and conversations on social media. There will also be a series of interviews with experts who will give their insights into how medical technology can care for patients and transform lives. You can visit the new website – www.medtechweek.eu - to browse all events happening across Europe during the week. How can I get involved? If you are a patient, health advocate, researcher, healthcare professional or stakeholder with an interest in medical devices and diagnostic tests, we want you to come on board. You can share your stories...
We are MedTech is a blog series highlighting employees of the medical technology industry and their work. Meet Ludovica Moccaldi. As a student I envisioned myself pursuing a job that had a positive impact on people’s lives and I am proud to be able to say that I have succeeded achieving this early in my career. I’ve found through my career that working in the MedTech industry makes you feel like you are part of something bigger, something meaningful, and something that touches people’s lives on a daily basis. Our work has a positive influence on the lives and wellbeing of thousands of patients and, in my opinion, that’s the best reward you can possibly receive. As a member of a health economic and reimbursement department at a major medical device manufacturer, my main responsibility is ensuring patients have access to world-class technologies. When I’m asked about what I do on a day-to-day basis, I always refer to my employers focus on ‘patient access’ instead of ‘market access.’ I do this because that’s why we collectively put every ounce of our energy and effort into our work: we want patients to have greater access to innovative technologies that can improve or save their lives. As in other sectors, working in the MedTech industry implies overcoming certain obstacles. We are continuously referred to as one of the most innovative and dynamic sectors in Europe. In many ways, it’s difficult for the wide-range of diverse stakeholders, and even the healthcare system itself, to keep up with the fast-pace environment that innovation brings to our industry. Our role is to educate and inform the various decision makers with factual, clinical and economic data that demonstrate the benefits of new therapies. Every day, I seek to work with key decision makers, or influencers, that...
  •